“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis” (2024) Farmeconomia. Health Economics and Therapeutic Pathways, 25(1). doi:10.7175/fe.v25i1.1568.